The gene encoding the splicing factor SF2/ASF is a proto-oncogene
By R. Karni, E. Stanchina, Scott W. Lowe, Rahul Sinha, D. Mu, Adrian R. Krainer. Nature Structural &Molecular Biology, 2007
937 citations recorded by the source corpus.
Subfields: Molecular Biology
View Paper: https://www.semanticscholar.org/paper/5f85c528919be955f619a572fdfd008429c8a8ce
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- J. Manley
- Qun Pan
- Benjamin J. Blencowe
- Charles J. David
- C. F. Bennett
- Susan M. Freier
- Asfar S. Azmi
- S. Prasanth
Citations in the corpus
- Broad targeting of resistance to apoptosis in cancer (2015, background): “Factors such as SF2/ASF and SC35 are associated with transformation may be upregulated in some tumors [123].”
- The Nuclear-Retained Noncoding RNA MALAT1 Regulates Alternative Splicing by Modulating SR Splicing Factor Phosphorylation (2010, background): “These AS events were previously reported to be sensitive to cellular levels of SRSF1 (Karni et al., 2007).”
- Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. (2010, background): “Consistent with this, Krainer and colleagues (Karni et al. 2007) demonstrated that the gene encoding SRSF1 can function as a proto-oncogene.”